Trends in the Annual Incidence of Carbapenem Resistant among Gram Negative Bacilli in a Large Teaching Hospital in Makah City, Saudi Arabia

Objective: To detect the prevalence of carbapenem resistance among Gram negative bacilli at the Al-Noor Specialist Hospital in the western part of Saudi Arabia. Materials and Methods: This study was conducted in the Microbiology department, Al-Noor Specialist Hospital, Makah city, Saudi Arabia. The clinical samples were collected from admitted patients in the wards, Intensive Care Units (ICUs), urology unit and surgery unit, these samples included blood, urine, sputum, pus and wound. The identification and antibiotic susceptibility testing of all bacterial isolates were performed via the Vitek 2 Compact System. Results: Out of 4803 Gram negative bacterial bacilli were isolated, the prevalence rate of carbapenem resistance among these isolates was 2797/4803 (58.23%), and sensitivity rate was 2006/4803 (41.77%) of the total isolates. The rate of resistance to carbapenem was among Acinetobacter baumannii 1710 (99.13%), followed by Pseudomonas aeruginosa 575 (62.4%), Klebsiella pneumoniae 459 (38%) and Escherichia coli 56 (5.59%). The trend of carbapenem resistance among Gram negative bacterial isolates from 2013-2015 was 53.99%, 59.88% and 61.43% respectively. Conclusion: A. baumannii rec-orded, the highest rate of carbapenem resistance through three year, 98.19%, 99.48% and 99.81% respectively and the lowest rate of resistance recorded with E. coli, 4.63%, 5.79% and 6.31% respectively.

[1]  B. Kakati,et al.  Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital. , 2017, Journal of clinical and diagnostic research : JCDR.

[2]  N. Ahmed,et al.  Antimicrobial resistance of bacterial isolates from respiratory secretions of ventilated patients in a multi-specialty hospital , 2015, Avicenna Journal of Medicine.

[3]  H. Giamarellou,et al.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.

[4]  M. Al-agamy,et al.  Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients , 2014, BioMed research international.

[5]  Z. Memish,et al.  The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  A. S. Attia,et al.  Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  L. Metwally,et al.  High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. , 2013, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[8]  M. Falagas,et al.  Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence , 2013, Antimicrobial Agents and Chemotherapy.

[9]  P. Tiwari,et al.  Assessment of Costs Associated with Hospital-Acquired Infections in a Private Tertiary Care Hospital in India. , 2013, Value in health regional issues.

[10]  E. A. Elsayed,et al.  High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. , 2013, Journal of medical microbiology.

[11]  K. Kaye,et al.  The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. , 2013, American journal of infection control.

[12]  P. Nordmann,et al.  NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  P. Nordmann,et al.  Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.

[14]  D. Livermore,et al.  Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia , 2012, Journal of chemotherapy.

[15]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[16]  Robert A. Bonomo,et al.  Carbapenems: Past, Present, and Future , 2011, Antimicrobial Agents and Chemotherapy.

[17]  M. Shorman,et al.  Emergence of extensive drug-resistant Acinetobacter baumannii in North of Jordan , 2011 .

[18]  P. Nordmann,et al.  NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. , 2011, The Journal of antimicrobial chemotherapy.

[19]  J. Patel,et al.  Carbapenemases in Enterobacteriaceae: Activity, Epidemiology, and Laboratory Detection , 2009 .

[20]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[21]  R. Bonomo,et al.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Robert A. Bonomo,et al.  Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .

[23]  D. Yong,et al.  Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp , 2003, Journal of Clinical Microbiology.

[24]  R. Gaynes,et al.  Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States , 1992, Infection Control & Hospital Epidemiology.